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Abstract
Chronic pain is the most prevalent health condition in the United States and is the most common
reason people seek healthcare (Chang, Daubresse, Kruszewski & Alexander, 2014). In 2012,
health care providers wrote 259 million prescriptions for opioid pain medications despite little
change in self-reported pain prevalence (Centers for Disease Control and Prevention (CDC)
2016; Chang et al., 2014). Initiatives to prevent the under treatment of pain have resulted in
overreliance on opioids to treat pain. As a consequence of opioid centric prescribing, an opioid
epidemic has evolved with devastating consequences such as dependence, addiction and
overdose deaths related to opioid overuse (CDC, 2016). Due to increased reliance on opioids for
chronic non-malignant pain management, the need for a chronic non-malignant pain protocol for
a primary care clinic was identified. Baseline data gathered to determine prescribing practices of
a rural primary care practice revealed a need for an evidence-based protocol to comply with State
of Michigan opioid laws. The protocol included evidence-based education, protocol and
electronic health record dashboard development and process evaluation. Implementation of a
chronic non-malignant pain protocol resulted in a decrease in opioid-only prescribing in primary
care and a 53% increase in multi-modal prescribing practices in a subsequent office visit for 141
patients over eight weeks. In addition, there was a significant increase in adherence with
mandated opioid prescribing practices such as: completed urine drug screen monitoring (p <
0.0001), signed opioid start talking forms (p < 0.0001), clinician reviewed drug prescription
monitoring (PDMP) (p < 0.0001) and chronic non-malignant pain contracts (p <0.0001). There
was no change in the documentation of patients pain score. Implementation of an evidencebased chronic non-malignant pain management protocol that adheres to Michigan law while
decreasing opioid-only prescribing results in significant quality improvement in healthcare
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delivery for primary care patients.
Keywords: multi-modal prescribing, chronic pain, primary care, pain protocol, Michigan opioid
law
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Implementation of Evidence-Based Chronic Non-malignant Pain Management
Protocol for Primary Care
Chronic pain is the most prevalent health condition found among the United States (U.S.)
work force and is the most costly in terms of lost production (Chen et al., 2016). The total
economic burden is estimated to be $78.5 billion with over one third of this amount ($28.9
billion) relating to the increased health care and substance abuse treatment costs (Florence, Luo,
Xu & Zhou, 2016). Chronic pain is defined as unpleasant sensory and emotional experience with
actual or potential tissue damage or described as damage lasting beyond the normal healing
period of three to six months (Owen et al., 2018). Chronic musculoskeletal pain (CMSP) is a
global health care concern with most individuals presenting to primary care settings for
management (Ernstzen, Louw & Hillier, 2017). Chronic musculoskeletal pain is classified as
part of chronic, non-malignant pain which encompasses musculoskeletal, neuropathic and
visceral pain (Ernstzen, et al., 2017). It is a complex condition that negatively impacts physical
and psychosocial health, daily function, life roles, healthcare utilization and health related quality
of life; therefore requiring multi-modal management (Ernstzen, et al., 2017).
Non-opioid medications such as non-steroidal anti-inflammatory drugs (NSAIDS) and
acetaminophen, are first line medication treatment for patients with mild to moderate pain
(Victor, Alvarez & Gould, 2009). However, opioid analgesics are among the most commonly
prescribed class of analgesics for both inpatient and outpatient settings (National Center for
Health Statistics, 2017). The use of opioid pain medication presents serious risks including
overdose and addiction. According to the Center for Disease Control [CDC] (2016), between
1999 and 2014, more than 185,000 persons died from overdose related to opioid pain medication
in the United States (National Institute of Drug Abuse, 2018), (Appendix A).
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The pressure on clinicians to treat pain has led to the increase in opioid reliance for
chronic pain management. Over the past several decades, the number of patients receiving
opioids and the number of doses prescribed have increased dramatically. Between 8% and 45%
of the population report chronic pain, with between 10% and 15% of the population presenting to
their primary care provider for treatment (McQuay & Moore, 2008). Prescribing for treatment of
chronic non-malignant pain with opioids changed from largely discouraged to being included in
standards of care. Recommendations for treatment of chronic non-malignant pain called for the
upward titration of opioid medication until the patient reported adequate pain control (Pletcher,
Kertesz, Kohn & Gonzales, 2008). In response, chronic non-malignant pain was often deemed
undertreated and initiatives to increase clinician identification and treatment of pain were
prompted. For instance, the American Pain Society promoted “pain as the fifth vital sign”, the
Joint Commission on Accreditation of Healthcare Organizations (JCAHO) created pain
management standards, and the World Health Organization (WHO) pain ladder was used by
providers and patients for a stepwise approach to pharmacological treatment of pain (Morone &
Weiner, 2013 & Vargas-Schaffer, 2010). As a result, opioids were increasingly prescribed for
first-line management of chronic pain. Between the years of 1999-2010, the quantity of
prescription analgesics sold to pharmacists and hospitals and prescribed by doctors increased by
400% (CDC, 2011). Regardless of the initiatives to combat under-treatment of pain with opioids,
the overreliance of opioids for chronic non-malignant pain has caused devastating consequences.
In 2012, health care providers wrote 259 million prescriptions for opioid pain medications
despite little change in self-reported pain prevalence (CDC, 2016; Chang et al., 2014).
A recommendation for first-line use of opioids for treatment of severe pain has been
promoted by the use of the WHO pain ladder (Blondell et al., 2013). However; it should be noted
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that the pain ladder was developed from expert opinion for cancer-related pain, and not built
upon higher levels of evidence, such as randomized controlled trials (RCTs) (Vargas-Schaffer,
2010). A letter to the editor of the New England Journal of Medicine further promoted
questioning the misconception of the safety of opioids. Porter and Jick (1980) reviewed nearly
12,000 hospitalized patients’ records for evidence of opioid addiction after receipt of at least one
opioid. The authors identified just four records with reasonable documentation of addiction; thus
concluding that opioid addiction is rare (Porter & Jick, 1980). A limitation of the letter to the
editor was that the population concerned only hospitalized patients whose treatments were
overseen by medical staff, and was never intended to have any bearing on analgesic use outside
short-term hospital visits.
As a consequence, efforts to decrease reliance on opioids for chronic non-malignant pain
management have emerged. The CDC (2016) released guidelines providing recommendations
for primary care providers prescribing opioids for chronic pain (Appendix B).
Recommendations were associated with lack of evidence showing long term benefits of opioids
versus non-opioids in pain management and improved daily functioning, as well as the possible
harms of opioids including overdose and overuse (CDC, 2016). In addition, various policies and
regulatory approaches have been initiated addressing morbidity and mortality related to
prescription drug abuse and misuse. The state of Michigan enrolled House Bill No. 4408,
section 7303c subsection 1 (2017) which set forth mandates for any providers prescribing
opioids in attempt to combat the opioid crisis (Appendix C). Determining the adherence to
evidence-based recommendations for chronic non-malignant pain and opioid laws is important in
order to improve care for this population, particularly in rural primary care practices with limited
resources. The clinical question addressed in the project: Does implementation of an evidence-
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based chronic non-malignant pain management protocol for opioid prescribing in primary care
lead to increased adherence to mandated state law opioid prescribing guidelines while also
decreasing opioid-only prescribing? A chronic non-malignant pain management protocol was
developed to reduce reliance on opioids for a rural Michigan primary care practice. In addition,
the evidence-based chronic non-malignant pain management protocol was implemented and
evaluated regarding adherence to mandated Michigan law and recommended CDC guidelines.
Assessment of the Organization
A feasibility assessment of the organization was conducted in order to be successful in
implementing and sustaining the quality improvement project. The organizational assessment
involved learning about the organization and discovering what is most important to the people
within that organization. The practice provides primary care to families at the community level
while meeting their increasing health and welfare needs. The organization’s current processes
and workflow were assessed and information was gathered from key stakeholders. Providers,
nurses, medical assistants (MA) and clerical staff were observed using current chronic nonmalignant pain management practices. The organizational assessment was guided by the Burke
& Litwin Model of organizational performance and change (Burke & Litwin, 1992) (Appendix
D). In addition, an analysis of the organization’s strengths, weaknesses, opportunities, and
threats in relation to implementation of an evidence-based chronic non-malignant pain
management protocol was performed.
Organizational Assessment Framework: Burke & Litwin
The Burke & Litwin Model was used to identify and define organizational dimensions
which are linked causally in order to promote and achieve change (Burke & Litwin, 1992). The
Burke & Litwin model represents how variables are inter-related within an organization and

11
Running head: CHRONIC NON-MALIGNANT PAIN PROTOCOL

impact the internal and external environment and individual and organizational performance
through a feedback loop process in a cause-and-effect relationship (Reflect & Learn, n.d.). This
model involves 12 key components with transformational and transactional dynamics. The
variables are illustrated in Appendix D (Burke & Litwin, 1992). The findings from the
organizational assessment of the primary care practice identified the need for improved
organizational and individual performance, improved systems including policy, standard work
and recognized external environment factors to improve care for patients with chronic nonmalignant pain.
Key Stakeholders
Influence of key stakeholders is critical to the success of a change-project (Moran et al.,
2017). Key stakeholders in a rural primary care practice are those involved with or affected by
the practice change. Including key stakeholders is vital while making a change within an
organization in order to maintain sustainability and be successful. The key stakeholders for this
project include the student’s mentor, who is the physician and owner of the primary care
practice, a nurse practitioner, practice manager who is also a registered nurse, three medical
assistants, a radiology technician, a coder/biller, two front desk staff and patients with chronic
non-malignant pain. Healthcare providers prescribe analgesics, patients receive the analgesics
and the community is affected by the rapid rise of opioid abuse. The physician owner of the
practice is responsible for generation of policy change. In the primary care practice, the
physician and nurse practitioner performed the assessments, the registered nurse was the project
champion for this project, and the medical assistants obtained the patients’ vitals and assisted
with process requirements and the front desk clerks scheduled the appointments.
Ethics and Protection of Human Subjects
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All data for this project was collected in a de-identified codebook (Appendix E). The
Doctor of Nursing Practice (DNP) student who acted as facilitator, was granted access to the
EHR for the organization for the duration of the project and kept all information on the secured
network provided by the organization. The reports on quality data were secured and stored in the
organization’s data base. An application for review and approval or exemption of this project
was submitted to the University Human Research committee for Institutional Review Board
(IRB). The project was determined to be non-research (Appendix F).
Current Practice
The current pain management practices of the practice were assessed. The analysis
identified the extent opioids were prescribed for patients with chronic non-malignant pain as well
as adherence to opioid law and CDC guidelines.
The baseline pharmacological chronic non-malignant pain management practices were
assessed with a report generated from the electronic health record (EHR). Data was retrieved
from the generated report on any patient currently prescribed analgesics for chronic nonmalignant pain management and determined the number of patients prescribed an opioid versus
non-opioid analgesic. Data was analyzed determining accurate diagnosis and pain prescribing
practices. Opioid analgesics included acetaminophen/hydrocodone (Norco), oxycodone,
morphine and tramadol. Non-opioid analgesics included non-steroidal anti-inflammatory drugs
(NSAIDS), pregabalin, tri-cyclic antidepressants, serotonin-norepinephrine reuptake inhibitors
(SNRI’s) and acetaminophen. For this analysis, it was assumed that if the patient had a current
prescription for the medication, they were taking the medication as prescribed.
Of the 403 patients prescribed analgesics for chronic pain management, 403 (100%) were
opioid-containing analgesics (Appendix G). Prescriptions were categorized by analgesic
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(Appendix H). Hydrocodone-acetaminophen was the most often prescribed opioid containing
analgesic (Appendix I), followed by tramadol and oxycodone. Morphine was the least prescribed
opioid containing analgesic. There was no indication in the charts that non-opioid NSAIDS such
as ibuprofen or non-opioid analgesics such as acetaminophen were used.
The secured data set, excluding patient names, was analyzed by patient record number
(PRN) and 10% or 40 of the 403 patients were randomly selected for manual EHR review.
Manual review was required due to the limited capability of the free EHR utilized by the primary
care practice to generate reports from data sets. The sample population (n=40) ranged in ages
from 26 to 90 of age with a mean age of 55.3 (standard deviation [SD] 14.8) years.
A patient reported pain score is assessed by a 0-10 scale indicting severity of pain. A pain
score was not recorded at the time of visit for a majority of the patients. All forty of the patients
had prescriptions for analgesics. Of the patients treated for chronic non-malignant pain, 100%
(n=40) were prescribed an opioid-containing analgesic.
The sample was also analyzed for usage of non-opioid medications as indicated for multimodal approach to chronic non-malignant pain management. Results yielded that none were
prescribed non-opioid NSAIDS or acetaminophen for chronic non-malignant pain. This
assessment further supported the need for development of a protocol that included an algorithm
for evidence-based multi-modal medication therapy as an approach to chronic non-malignant
pain management.
SWOT Analysis
A SWOT analysis, as shown in (Appendix J), was performed at the primary care practice
evaluating the organization’s strengths, weaknesses, opportunities and threats regarding current
process followed while caring for the patients with chronic non-malignant pain. Internal
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strengths of an organization are attributes that give an organization a competitive edge over its
competitors (Moran et al., 2017). An organization’s weaknesses are internal factors that can be
corrected. Opportunities are the forces in the external environment that the organization has no
control over but can influence how an organization functions (Moran et al., 2017). An
organization should always be invested in identifying growth opportunities. Threats are external
forces that an organization has no control over and if not anticipated can influence and cause
difficulty for the organization (Moran et al., 2017).
Strengths. Strengths to support practice change were identified. The clinic is a growing
family practice that nurtures a consistent environment by retaining patient familiar providers and
staff. The physician owner of the practice is aware and supportive of the current opioid laws
driving the needed change providing a welcoming environment for practice change. In addition;
the small size of the organization and management structure facilitated the opportunity for quick
practice change.
Weaknesses. Weaknesses in relation to pain management practice change were
identified. Since the clinic is fairly new and still developing its internal processes, Practice
Fusion, a free EHR is utilized, but has limiting reporting capabilities. Patients were assigned a
variety of ICD-10 diagnosis codes, none of which indicated chronic non-malignant pain. The
practice also lacked a formal written chronic non-malignant pain management protocol for
adherence to the recommended CDC guidelines to reduce opioid abuse. In addition, the clinic
was not utilizing evidence-based recommendations for chronic non-malignant pain management.
An additional concern about implementation of a chronic non-malignant pain management
protocol was increased workload for front office staff. The clinic has a small number of staff and
determining the responsibility for additional tasks was perceived as burdensome by front office
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staff and medical assistants.
Opportunities. The location of this practice presented a potential opportunity as it is the
only independent primary care clinic for several surrounding counties. There was an opportunity
to develop an effective protocol for chronic non-malignant pain management and to increase
adherence to state mandated guidelines resulting in decreased opioid-only prescribing. The
external environment showed many incentives to implementation of guidelines for opioid
therapy including the reduction of inappropriate prescribing and harmful effects such as
addiction and overdose (Zgierska et al., 2018; Quanbeck et al., 2018). In addition, implementing
an evidence-based chronic non-malignant pain management protocol had the potential to
improve quality care.
Threats. Threats were also identified for the project. Many existing patients had
transferred from other primary care practices with existing opioid prescriptions. Patients treated
for chronic non-malignant pain require a complex individual assessment in a relatively limited
time of an office visit. Implementing an evidence-based chronic non-malignant pain management
protocol could cause a threat to the organization by increasing appointment duration and as a
consequence, a loss of revenue. Threats to the practice in relation to chronic non-malignant pain
management practice change include patients’ preference for opioids, reimbursement tied to
patient satisfaction, and potential that the staff may resist the practice change. More importantly,
the practice may incur penalties for not following the mandated laws regarding opioid
prescribing now in force in the state of Michigan.
Evidence-Based Initiative
In order to determine evidence-based best practices, a review of the literature was
conducted. Initially, the review focused exclusively on chronic pain, but the search was
narrowed to focus on literature regarding chronic non-malignant pain in primary care.
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Method
The Preferred Reporting Items for Systemic Reviews and Meta-Analyses (PRISMA)
guideline served as the framework for this review (Moher, Liberati, Tetzlaff, Altman, &
PRISMA Group, 2009). A comprehensive electronic search was conducted in the PubMed,
CINAHL and Cochrane databases and was limited to reviews in the English language during the
period of 2007 to 2018. Keywords were multi-modal, combined analgesia, pain, opioid sparing,
primary care, opioid consumption and pain management. Inclusion and exclusion criteria were
tailored to the characteristics of the primary care practice. The focus of the literature review was
to compare multi-modal analgesic therapy to monotherapy with one of the agents used in the
intervention group. The questions considered in the literature review were fourfold:


Does use of multi-modal analgesia result in improved pain management in chronic nonmalignant pain than analgesic therapy with a single agent?



Does multi-modal analgesia result in decreased opioid consumption than analgesic
therapy with a single agent?



Does the implementation of practice guidelines for opioids result in a decrease of overall
opioid prescriptions?



Does the use of a clinical tool improve provider adherence to opioid prescribing
guidelines?

PRISMA Review
The search resulted in 163 CINAHL, 185 PubMed and 150 Cochrane reviews (Appendix
K). After screening and in depth examination of the studies, 9 articles were included in the
literature review (Appendix L).
Summary of Results
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This literature review completed focused on opioid and non-opioid medications
prescribed for chronic non-malignant pain in the adult population in primary care. The goal was
to determine an evidence-based method to improve chronic non-malignant pain management
while decreasing opioid-only prescribing and increasing adherence to state mandated guidelines.
Multi-modal analgesic results. Findings of this literature review suggested multi-modal
therapy of at least two analgesics with different mechanisms of action can produce better and
longer pain management without increasing adverse effects (Chaparro, Wiffen, Moore, & Gilron,
2012; Ramiro et al., 2011; Gatti et al., 2009; Romano et al., 2009). Three studies concluded that
multi-modal analgesic therapy is superior to the use of a single drug therapy (Chapparo et al.,
2012; Gatti et al.; 2009 & Romano et al., 2009). Two reviews found evidence supporting multimodal analgesia over single therapy but did not make definitive conclusion (Khoromi et al.,
2007; Ramiro et al., 2011). The final review concluded that opioid therapy was not found to be
more beneficial or effective in increased pain control then non-opioid therapy (Kreb et al., 2018).
Chronic non-malignant pain protocol results. The review also showed that
implementation of an opioid tool was effective in increasing opioid guidelines in primary care. In
these studies, a clinically significant change was reported as a percentage. One study concluded
that adding a dashboard in the EHR increased treatment agreement by 14%, urine drug testing
(UDT) increased by 20%, a completed pain functional assessment increased by 11%, and a
clinically significant decline in patients receiving opioid prescriptions by 12.5% (Anderson et al.,
2015). Obtaining UDT is important in a chronic non-malignant pain management protocol
because if the UDT is positive for drugs of abuse, no opioids should be prescribed. One study
concluded that implementation of a risk assessment tool resulted in a 14% drop in patients
receiving any opioid prescription, a 19% drop in chronic opioid patients and chronic opioid urine
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drug screening increased 87% (Chen et al., 2016). The final study revealed that after
implementing a opioid tool (TOPCARE), 28% more patients had guideline concordant care, a
59% increase in opioid agreement, a 17% increase in UDT and greater discontinuation of
opioids with an overall 10% dose reduction or discontinuation of opioid use (Kreb et al., 2018).
Conclusion
Overreliance and prescribing of opioids for the treatment of chronic non-malignant pain
is a public health issue that has led to the current opioid crisis. This review of literature revealed
that multi-modal analgesia is an effective alternative approach to treating chronic non-malignant
pain. Opioids will continue to play an important role in chronic pain management but can no
longer be considered the primary analgesia class for chronic non-malignant pain. The findings
offer evidence that changing chronic non-malignant pain management practices with multimodal therapy and implementing opioid guidelines in primary care could impact the opioid crisis
and provide safe and effective alternatives while adhering to state mandated guidelines.
Phenomenon Conceptual Model
For successful implementation and sustainability of this project, both a theoretical and an
implementation model served as guide for project application. The theoretical model used to
describe the phenomenon for this project was the Promoting Action on Research in Health
Sciences (PARiHS) framework (Appendix M). The implementation model used for this project
was Kotter’s eight steps of change (Appendix N).
Theoretical Model: PARiHS
The (PARiHS) framework (Appendix M) is described by the equation where successful
implementation is a product of the nature of the evidence, the context of the proposed change,
and the mechanism of facilitation (Kitson, Harvey, & McCormack, 1998). The phenomenon is
changing opioid prescribing practice for chronic non-malignant pain management using
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evidence-based guidelines. PARiHS is a multidimensional framework that was developed to
represent the complexity of implementing research-based practice to assist with successful
practice change (Rycroft-Malone, 2004). The framework has been utilized by clinicians to
improve the quality of care by setting clinical standards, introducing audit and quality
improvements, and in changing patient services in several different health care settings (Kitson et
al., 2008). Therefore, the PARiHS framework was best utilized to explore facets of change
needed to facilitate opioid prescribing practices and the need for a chronic non-malignant pain
management protocol in primary care.
Evidence. Kitson et al. (1998) defines evidence as the combination of research, clinical
expertise and patient choice. Research ranges from low quality (anecdotal and descriptive) to
high quality (systematic reviews, randomized controlled trials [RCTs]), and evidence-based
guidelines). Professional consensus, or clinical experience, incorporates a spectrum of low
consensus (divided expert opinion) to high consensus (consistency of view). The higher the
level of research quality, the more successful the organization will likely be with a quality
improvement change.
There is a significant amount of evidence supporting an evidence-based chronic nonmalignant pain management protocol. Evidence clearly suggested that multi-modal medication
management for chronic pain is significantly better than monotherapy (Chaparro, Wiffen, Moore,
& Gilron, 2012; Ramiro et al., 2011; Gatti et al., 2009; Romano et al., 2009). The Joint
Commission and the Institute for Clinical Systems Improvement recommended the combination
of opioids with non-opioids in order to reduce the reliance on opioids for pain (The Joint
Commission, 2012; Thorson et al., 2014). Providers were expected to include the patient in the
treatment plan for managing chronic non-malignant pain. It was encouraged that providers share
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the patient educational flyer that provides evidence for multi-modal analgesia when presenting
patients with non-opioid alternatives to treat chronic non-malignant pain. Evidence also revealed
that opioid prescribing tools in primary care including EHR dashboards, opioid treatment
agreements, urine drug testing, pain and functional assessments and patient education also
reduced the overreliance of opioids for chronic pain (Anderson, Zlateva, Khatri, & Ciaburri,
2018; Chen et al., 2016).
Context. The definition of context is the environment or setting where the proposed
changed will occur (Kitson et al., 1998). Context can be viewed as the forces at work that give
the environment its character and mood. Context includes culture, leadership, and the
measurement of systems and services (Kitson et al., 1998). The leadership in the primary care
practice was supportive of innovation and changes; therefore creating an environment
instrumental to practice improvements. The physician owner of the practice was responsive to
practice change and the employees shared the same values and vision. The culture within the
practice was supportive of improvement initiatives. Staff members were encouraged to
communicate openly when a problem arose and contributed at monthly staff meetings to discuss
resolution. The practice change emphasized patient-centered care by encouraging the providers
to partner with the patients to promote and utilize multi-modal analgesia. The providers were
expected to use an evidence-based protocol utilizing both opioid and non-opioid options for
chronic non-malignant pain management. The rural primary care practice had limited resources
to develop the structure and processes needed to comply with mandated state guidelines,
therefore the project work by the DNP student facilitated the quality improvement initiative in
the practice.
Facilitation. Facilitation refers to a technique by which a person can make things easier
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for others (Kitson et al., 1998). The facilitator for the project was the doctor of nursing practice
(DNP) student. The staff and providers were open to education regarding the current opioid crisis
and evidence-based chronic non-malignant pain management protocols. A facilitator is vital to
the success or failure of the implementation of research into practice (Kitson et al., 1998). To
increase facilitation, the DNP student recognized and removed barriers. Further facilitation of
this DNP project required the student to display respect and flexibility to ensure the success of
this practice change. The DNP student addressed concerns and suggestions for the project from
all staff members throughout the entire project. The DNP student was empathetic and worked
through any disruption of workflow of the change process. The DNP student presented with a
unique skillset that assisted with challenges that arose with project implementation. The
PARiHS framework also assisted with insight to the phenomenon and provided the facilitator
with guidance to complete this quality improvement practice change.
Implementation Model: Kotter’s Eight Step Change Model
Kotter’s eight step change model served as the guiding framework that promoted the
success of this practice change during implementation (Appendix N). After observing more than
100 companies attempt transformation, Kotter created the model (Kotter, 1996) that identified
three phases, consisting of eight steps that are necessary to implement the fundamental changes
needed in the practice regarding adherence to an evidence-based chronic non-malignant pain
management protocol.
Creating climate for change. The first phase of Kotter’s eight step process is creating a
climate for change. This includes the first three steps of Kotter’s eight step process: a sense of
urgency, forming a powerful coalition and creating the vision for change (Kotter, 1996). To
create a sense of urgency, the facilitator must inspire the clinic staff that there is an opportunity
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that must be acted on immediately (Kotter International, 2017). The evidence revealed the opioid
crisis and state mandated opioid prescribing guidelines had created a sense of urgency in the
primary care practice. The providers and staff shared the vision that current prescribing practices
for chronic non-malignant pain management needed to change. When a vision is created, staff
will take personal claim to the change and adapt to the strategies necessary to achieve the vision
(Kotter International, 2017).
Engaging and enabling the organization. The second phase of Kotter’s eight step
change model is engaging and enabling the organization. This includes the next three steps of
Kotter’s eight step process: communicating a vision, empowering action and engaging and
enabling the organization (Kotter, 1996). The vision was unified with leadership support for the
protocol change throughout the practice. Educating the staff on the opioid crisis and how their
involvement in an evidence-based chronic non-malignant pain management protocol could
improve the quality for the patient and community empowered action. Engagement of the staff
was gained by educational sessions and by encouraging staff to share their ideas. This phase also
included the creation of an evidence-based protocol and preparing the EHR for utilization.
Barriers to action must be identified and removed to promote the freedom necessary to create
real impact (Kotter International, 2017).
Implementing and sustaining for change. The last phase of Kotter’s eight step
change model is implementing and sustaining change. This includes the last two steps of Kotter’s
eight step process: building on change and making it stick (Kotter, 1996). Instead of assuming
victory after the first signs of improvement, data was used to show that the practice changes were
working therefore inspiring more people to be on board to continue the effort. The process was
reinforced using evidence-based tools such as dashboards impacting practice change, decreasing
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opioid-only prescribing, and increasing compliance with prescribing guidelines preventing any
future penalties the state may impose for primary care. Identifying and utilizing change
champions within an organization is an evidence-based strategy for increasing understanding of a
practice change (Kaasalainen et al., 2015). The practice manager agreed to be the champion and
needed continual mentoring by the DNP student to promote sustainability of the practice change.
Partnering in the implementation effort requires building a coalition and recruiting with others
(Powell et al., 2015). Finally, it is important that any new addition to staff be on board with the
practice change, fostering sustainability. This was achieved by placing education about vision,
opioid prescribing and a copy of the protocol in new employee folders. The practice manager
mentored new staff ensuring adherence to the evidence-based practice change.
Project Plan
Purpose of Project
The purpose of the DNP project was to develop, implement and evaluate an evidencebased chronic non-malignant pain management protocol into the standard of care in a rural
primary care practice. Additionally, following the protocol promoted adherence with state law as
well as CDC guidelines regarding opioids. The project was developed to answer the clinical
question: Does implementation of an evidence-based chronic non-malignant pain management
protocol for opioid prescribing in primary care lead to increased adherence to mandated state law
opioid prescribing guidelines while also decreasing opioid-only prescribing?
Objectives and Implementation Strategies
To ensure that the clinical question, purpose and objectives of this DNP project were
addressed using Kotter’s eight step change model as a guide for implementation. (For the project
timeline, Appendix O).
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1. Created a sense of urgency: Beginning May 2018, meetings were held with key
stakeholders including the practice owner, physician and practice manager to begin the
initial plans of the project.
2. Created a coalition & created a vision. The DNP student met with office staff in
August 2018 regarding chronic non-malignant pain management protocol. The staff was
supportive of the project and the practice manager agreed to champion the pilot project.
The vision of addressing the opioid prescribing issues in the practice was created and
supported by the staff.
3. Communicated the vision: The vision for the project was communicated by the
physician during the November staff meeting. Education regarding an evidence-based
chronic non-malignant pain management protocol for the providers and staff was
provided during the week of December 1, 2018.
4. Empowered action: The DNP student collaborated with the physician prior to December
1, 2018 to discuss evidence for the project. The physician is the owner of the practice
and the main opinion leader and provider of the clinic. Fostering this partnership
encouraged colleagues to adopt an evidence-based pain management protocol into the
standard of care (Powell et al., 2015).
5. Created quick wins: The DNP student continued to cultivate relationships with the
clinic staff and requested their promotion of the project. Staff meetings were held prior
to December 15, 2018 with steps needed to promote the project. Every Friday after
December 15, 2018, a weekly audit including evaluation variables and feedback was
provided to the staff. The feedback data was used as encouragement to staff to build on
successes.
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6. Built on the change: The project concluded after 60 days of implementation. Final
report to the practice included percentage of overall adherence to the protocol and
percentage change in opioid-only prescribing by March 15, 2019. Project products
including the protocol were incorporated into practice processes and staff educated on
maintaining change process. The worksheet remained part of the EHR after final
evaluation of the protocol.
7. Made it stick: The DNP student mentored staff to continue dashboard and monitoring of
protocol adherence to sustain the change. Additionally, educational flyers were placed in
any new staff members’ orientation folder to ensure new staff members had consistent
orientation to the protocol. Recommendations for staff and providers to continue to
monitor opioid prescribing practices were also considered.
A protocol which included an EHR worksheet, opioid guidelines and educational flyers
for patients was developed. Multi-modal analgesia evidence was presented to the physician,
nurse practitioner and practice manager in an informal educational session and an evidencebased worksheet was created and used with every chronic non-malignant pain management
patient starting January 3, 2019 and ending March 3, 2019 (Appendix P). The evidence-based
worksheet included multi-modal chronic non-malignant pain management and evidence-based
guidelines and was incorporated into the EHR.
The educational flyers were created and provided to staff. The flyer included an
algorithm for evidence-based chronic non-malignant pain management, tips and reminders for
providers to order multiple analgesics with different mechanisms of action. Patient education
flyers were created and included new state law requirements, CDC recommendations, and
benefits of multi-modal therapy and risks of opioid reliance. Printed educational materials are
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effective strategies to promote practice change (Farmer et al., 2008). A fifteen minute
presentation regarding evidence supporting the practice change and strategies to promote the
change was presented to staff. Education was provided to the RN and medical assistants on
multi-modal chronic non-malignant pain management before intervention. During initial patient
appointment, the physician or nurse practitioner provided the patient with the educational flyer
informing the patient regarding the chronic non-malignant pain management protocol, new state
law and CDC guidelines. A signed copy of the state mandated opioid start talking education form
was scanned into the chart for each patient (Appendix Q).
Interventions such as feedback and educational meetings can help change professional
behaviors and improve patient health outcomes (Forsetlund et al., 2009). Providing written and
verbal education to patient’s also assisted with acceptance and compliance to practice change.
Audit and feedback was the summary of clinical performance data that allowed for monitoring,
evaluation and behavior modification (Powell et al., 2015).
Implementation of best practices into standard of care is increased with the use of the
EHR (O’Connor, DeCaire & Freidrich, 2005; Ozdas et al., 2006; Santolin & Boyer, 2004). The
EHR is a free electronic health record called Practice Fusion, which did not have the capability
of creating order sets. Order sets are designed for a specific patient population and reports can be
generated from an order set. Since the EHR lacked reporting capability, worksheets were created
for this specific patient population for collection of data, which required considerable facilitator
time.
All analgesics for chronic non-malignant pain management prescribed in the practice
between January 3, 2019 and March 3, 2019 which included two subsequent office visits that
addressed pain management and percentage of adherence for each of the following variables
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were measured: patients prescribed opioid only/multi-modal/non-opioid only analgesics, charting
of completed UDS, PDMP, pain score, signed chronic pain management contract, and patient
signed opioid education scanned into the chart (Appendix E).
Design for Evidence-based Initiative
The quality improvement project incorporated an evidence-based practice protocol
regarding chronic non-malignant pain management into a rural primary care practice. The
purpose of the quality improvement project was to change the delivery of healthcare through a
systematic method to produce improved patient outcomes (Tasker, 2013). The project work
included development, implementation and evaluation of a protocol for primary care to reduce
reliance on opioids and increase adherence to mandated Michigan law and recommended CDC
guidelines.
Setting and Required Resources
This DNP project took place in a rural primary care practice in West Michigan.
Resources required for completion of this project included technology, people and educational
materials. The EHR was the technology necessary for completion of this project. The limited
reporting of a free EHR necessitated manual retrieval of pre and post- implementation data for
each chronic non-malignant pain management patient for two visits within the designated time
period. Human resources needed for the project included time from clinic staff (three MA’s and
two front office staff) and clinic leadership (physician, NP and practice manager RN). In
addition, an in-kind donation of DNP student time was used to facilitate the project.
Participants
The participants for this project included providers, practice staff and data collected from
de-identified patients in the practice diagnosed with chronic non-malignant pain with two office
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visits between January 3, 2019 and March 3, 2019.
Data Collection and Analysis
Measuring data was essential to determine baseline practice and post-intervention change
after protocol initiation. Data was collected through EHR chart review, checklists and
observation. Use of multi-modal medication was determined by EHR chart review and feedback
on protocol performance was provided for the staff weekly.
Adherence to the protocol was measured by percentage change pre-implementation
compared to post-implementation on two subsequent patient visits between the dates of January
3, 2019 and March 3, 2019. Variables that were measured during this time frame included
charting of completed UDS, PDMP, pain score, signed chronic pain management contract and
patient signed opioid education (Appendix D).
Change in prescribing from opioid-only prescribing to multi-modal prescribing was also
measured. The types of medications ordered per patient were evaluated from two visits between
January 3, 2019 and March 3, 2019. The implementation of the protocol was reviewed for every
patient prescribed an opioid for chronic non-malignant pain for two consecutive visits over the
course of the pilot study to determine adherence. Chronic non-malignant pain management
patients are required to have an office visit once every 30 days, therefore data was collected on
two visits per chronic non-malignant pain patient. The study was limited to two visits as it is a
pre-post evaluation in which baseline status was accessed, the intervention was implemented and
a single follow-up measurement was collected. No more than two visits (one paired set) were
included in the pilot study.
A change in prescribing practice was determined by number of change from initial visit
to second visit. An increase in multi-modal analgesia in comparison to opioid-only chronic non-
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malignant pain management defined that the clinicians adhered to the evidence-based medication
algorithm protocol.
Overall adherence to multi-modal prescribing was evaluated as well as each variable
included in the protocol was analyzed separately pre and post-implementation. Appropriate
analysis including the McNemer percent version of chi-square for paired data was applied to
assess change in adherence to protocol variables as well as opioid prescribing. Any percentage
increase in adherence was considered successful practice change.
If adherence to the protocol was low, efforts were made to promote increased adherence
during weekly feedback. Weekly audits were presented to providers including frequency and
percentage of patients receiving opioid-only, multi-modal, or non-opioid therapy. Success was
determined by progressively improving audits weekly. Final evaluation of the implementation of
an evidence-based chronic non-malignant pain management protocol that adheres to state law
and CDC guidelines occurred 60 days after the start of implementation.
Budget
The budget for this DNP project was determined (Appendix R). Most of the expenses for
this project were in kind donation by the DNP student serving as the facilitator. The DNP student
consulted with another primary care practice and examined how that practice developed,
implemented and evaluated a protocol for chronic non-malignant pain management.
Potential cost savings of the plan to limit the primary care clinics’ contribution to the
opioid crisis was considered as well. With the new laws regarding opioids, primary care
providers will eventually be subject to penalties for non-adherence that have yet to be
determined. In Michigan, the rate of opioid-related admissions was 229.6 per 100,000 people in
2014 (Weiss et al., 2016). The population of the rural Michigan county was 63,550 in 2017
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(United Census Bureau, 2017). Using these statistics, it was calculated that in 2017 there were
145 opioid- related hospital admissions for the people of the county. The average hospital length
of stay when admitted for opioid-related overdose was 3.8 days while costing $29, 497
(Bachhuber, Saloner, Cunningham, & Barry, 2014). Therefore; if only one opioid-related
hospital admission were prevented in the future as a result of this DNP project, nearly $30,000 in
hospital costs would potentially be mitigated.
Results
Analysis. The methods to analyze the data were quantitative. The data was analyzed by
viewing the data in an excel form and on graphs. When working with paired data, divergent pairs
were identified and McNemars test used to determine a p value of categorical outcomes.
Divergent pairs are used to identify the accumulation of differences between closely related
patterns pre and post-implementation. A Kappa test was tabulated to report statistical value.
Kappa serves to quantify how many patients status changed versus stayed the same from time
one to time two. A Kappa of -1 means that no person had the same value at time two as they did
at time one. A Kappa of 1 would mean everyone had identical scores. This study revealed a
Kappa score of 0.636. Kappa is less informative than reporting percentages as it lacks content
but is used in this analysis because it shows categorical change for medication prescribing
practices.
The data was examined pre and post-implementation of the protocol. Pre-implementation
chart review indicated that prescribing practices were opioid centric with limited multi-modal
prescribing. Additionally, chart review revealed limited completion of a documented pain score,
completed UDS, opioid contract, PDMP screening and patient opioid education for all chronic
non-malignant pain patients. The study population (n=141) ranged in ages from 23 to 86 of age
with a mean age of 52.45 (standard deviation [SD] 13.67) years.
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Post-implementation revealed increased multi-modal prescribing and a decrease in
opioid-only prescribing (Appendix S). Kappa value revealed that 93/141 patients changed status.
Of these patients, only one patient changed from non-opioid to opioids while 75 patients (53%)
changed from opioid only to either non-opioid or multi-modal management. Change of
prescribing in the practice resulted in increased multi-modal prescribing (Appendix T & U).
Individual medications prescribed revealed the most significant increase in prescribing with
NSAIDS (26.95%) and pregabalin (29.87%) (Appendix V). Chart review revealed completed
urine drug screening increased by 74.47% (p < 0.0001), opioid contracts increased by 85.82% (p
< .0001), prescription drug monitoring increased by 96.45% (p< 0.0001) and patient opioid
education for patients increased by 74.47% (p< .0001) (Appendix W). There continued to be a
lack of documented pain score for any patient in the pilot study which resulted in insignificant
results.
Limitations
Limitations to this project included that data was analyzed based on what was
documented in the EHR and may not be a true reflection to patient choices of non-prescription
medications. Also, the organization is a small privately own practice utilizing a free EHR with
limited function, therefore requiring all data to be retrieved manually. Lack of a documented
pain score limits the ability to assess reasoning for medication prescribed for chronic nonmalignant pain. Lastly, during the last weeks of the project the DNP student was notified that the
practice would be closing as of April 26, 2019 hindering sustainability.
Discussion
This project was initiated in a rural primary care practice with limited resources due to
recent state mandates regarding opioid prescribing for chronic pain and the increase in mortality
related to opioid overdose in Michigan. Evidence-based protocols for opioid prescribing can be
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implemented to improve outcomes for this population. This project also aimed to improve
prescribing practices with the use of multi-modal medication management protocol for chronic
non-malignant pain.
During this project, process frameworks were used to organize the approach. The BurkeLitwin model was used to thoroughly analyze the needs for chronic non-malignant pain
management practices at this organization. The PARiHS framework was used to understand the
evidence and to develop and facilitate a practice change. A SWOT analysis was performed to
determine areas in need of improvement and areas of strength at the organization. The purpose of
the project was to identify the gaps in care in primary care practice to guide recommended
evidence-based change and improve outcomes.
The success of the project can be contributed to the change in culture in the organization.
Leadership and staff acceptance and adherence to evidence-based practice, protocol
implementation and the quality improvement process was imperative, resulting in significant
changes in all the measured outcomes. Results of the project successfully answer the clinical
question of this project. Implementation of a chronic non-malignant pain protocol increased
multi-modal prescribing resulting in decreased opioid-only prescribing. In addition, the protocol
increased adherence to state of Michigan opioid laws.
Implications for Practice and Further Study in the Field
The project addresses major implications for practice. The opioid crisis is an established
and growing issue. Overreliance of opioids to treat chronic non-malignant pain has led to
devastating outcomes such as addiction and overdose. The majority of patients seek treatment for
chronic disease in primary care. Implementation of an evidence-based chronic non-malignant
pain management protocol that adheres to Michigan law and improves patient care is critical in
primary care.
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The project highlights the need for DNP prepared facilitators for primary care practices
with limited resources to develop, implement and evaluate quality improvement. In addition, an
organization’s project champion is critical to the continued processes and evaluation of quality
improvement projects of the clinic.
Quality improvement projects that result in policy change consistent with existing and
emerging state laws regarding population health improve quality of care for the patient and
community served. Implementing policies adhering to Michigan opioid laws, resulting in the
improvement in health of this patient population ultimately decreases organizational contribution
to the opioid crisis.
Sustainability
Even though this practice is closing, lessons learned are that chronic non-malignant pain
management can be successfully impacted by implementation of an evidence-based protocol,
even in a rural primary care practice with limited resources. Ongoing evaluation of opioid
prescribing practice would be greatly impacted by the upgrade in technology of an EHR with
report generating capabilities. It is imperative to have continued acceptance by all staff to ensure
continued protocol adherence. Adherence can be achieved by weekly communication with staff
regarding successful change and guidance when difficult issues arise. A project champion would
continually need to mentor staff on protocol adherence and perform periodic chart review to
share with staff. Lastly, it is important to consider staff in a primary care practice who would be
responsible for ongoing monitoring, reporting and educational materials needed for
sustainability.
Dissemination of Results
The DNP project will be presented as part of the DNP student’s final defense at Grand
Valley State University (GVSU) April 16, 2019. The outcomes will also be shared with the staff
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at the primary care practice during a staff meeting in April 2019. Finally, the DNP student will
seek out opportunities to report the outcomes to relevant professional journals and presentation
to professional organizations as well as submission to ScholarWorks.
Reflection of DNP Essentials
The Essentials of Doctoral Education for Advanced Nursing Practice (AACN, 2006)
were the guiding competencies the DNP prepared nurse gained by project work and immersion
activities during curriculum.
Essential I: Scientific Underpinnings for Practice
AACN (2006) essential I focus is on using theory to guide practice improving delivery of
healthcare for the healthy and sick, assess and implement new practices and evaluate outcomes.
This project focused on evidence to determine the best care to be provided to patients with
chronic non-malignant pain. Also, frameworks such as the Burke and Litwin model for change,
PARiHS and Kotter’s eight steps for change were utilized to identify, define and guide the
practice change (Burke & Litwin, 1192; Kitson, Harvey, & McCormack, 1998; Kotter, 2017).
Essential II: Organizational and Systems Leadership
DNP essential II focuses on understanding an organizations hierarchy and how leadership
within that organization collaborates to minimize disparities in healthcare and promote safety
(AACN, 2006). Leadership support is monumental in order to initiate, create and maintain
change. The DNP student demonstrated this essential through theory-guided organizational
assessment to determine the context of the clinical problem. This information was also utilized to
determine the unique needs of chronic non-malignant pain management patients in this rural
primary care practice. In addition, a budget plan for the DNP project was created.
Essential III: Clinical Scholarship and Analytical Methods for Evidence-Based Practice
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According to the AACN (2006), the DNP student should be prepared to translate and
disseminate evidence-based research into practice. The goal was to locate relevant and
applicable evidence related to the chronic non-malignant pain patient using the PRISMA method
in order to provide evidence and evaluate relevant variables. The quality improvement project’s
goal was to improve patient care and outcomes for the population of focus. Data was collected
from the EHR and manually entered into an excel sheet which was further analyzed with a
statistician.
Essential IV: Information Systems Technology
The ability to understand and utilize systems technology to obtain information, analyze
and display data is imperative. The DNP student needs to understand the legal, ethical and
regulations that surround the using the system to evaluate outcomes for programs, provided care
and systems (AACN, 2006). The student utilized the organization’s EHR to gather data to
formulate the dashboard for provider and staff feedback. As data was retrieved and analyzed,
special consideration was taken to promote confidentiality and protect patient information. In
addition, the DNP student attended a conference on the importance of systems technology as it
improves the quality of healthcare delivery, increases patient safety, decreases medical errors,
and strengthens the interaction between patients and healthcare providers.
Essential V: Advocacy for Health Care Policy
A DNP student needs to understand the importance of healthcare policy and application
to nursing practice. This essential focuses on policy change in relation to decisions within an
institute, organizational or government level (AACN, 2006). The student participated in
Advocacy Day for Nurse Practitioners at the capitol to increase awareness of current policy and
laws. The DNP project involved policy and practice change by implementing an evidence-based
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chronic non-malignant pain protocol resulting in clinically significant results in a primary care
practice.
Essential VI: Interprofessional Collaboration
This essential focuses on the collaboration between healthcare teams with the student
establishing interprofessional teams (AACN, 2006). The DNP student had a leadership role
collaborating with multiple interdisciplinary teams to make an impact and receive support while
implementing a practice change. Collaborating with providers, medical assistants, the practice
manager and front desk staff was essential for successful practice change. The DNP student also
attended the interprofessional conference in September 2018 at GVSU. This conference focused
on the importance of healthcare providers and professionals collaborating as a team to improve
patient and population health care.
Essential VII: Clinical Prevention and Population Health
The DNP student needs to promote health and reduce risk of illness while understanding
epidemiology, environmental, bio-statistical regards to a populations’ health (AACN, 2006).
This DNP project directly focused on chronic non-malignant pain management patients and
application of an evidence-based protocol to improve outcomes. Chronic non-malignant pain is
a serious public health problem in addition to opioid centric prescribing, resulting in poor
outcomes and increased mortality.
Essential VIII: Advanced Nursing Practice
The DNP role is diverse and has the ability to analyze a complex system, design and
implement best practice for a patient population, develop a sustainability plan, maintain
professional relationships with several different specialties in order to improve outcomes of care
and standardize processes of care (AACN, 2006). The DNP student’s lens assisted in the
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successful approach to this project work. The DNP student analyzed an organization, identified a
need for practice change, performed research, developed and implemented a policy change that
is sustainable. The DNP student also attended the Michigan Nursing Summit in Lansing on
October 18-19. The DNP student collaborated with many other nurses and nurse practitioners
and learned about mentorship for future nurses by expecting excellence instead of perfection.
Conclusion
In conclusion, the project presented a compelling case for an evidence-based chronic
non-malignant pain management protocol that incorporated staff education, EHR worksheet
utilization, multi-modal medication prescribing and practice guidelines. The project is a valuable
contribution to the decrease of opioid prescribing by promoting an evidence-based practice
regarding chronic non-malignant pain management and adherence to state mandates and CDC
guidelines in a rural primary care practice with limited resources. The goal was to provide
evidence-based care in order to improve outcomes and prevent morbidity and mortality for the
rural primary care population. Educating staff in regard to the chronic non-malignant pain
management protocol and EHR utilization can have positive outcomes not only on quality
documentation and reporting, but also improved patient outcomes. The chronic non-malignant
pain protocol implemented resulted in a decreased percentage of opioid-only prescribing while
increasing evidence-based multi-modal prescribing practices. In addition, the protocol resulted in
an increased adherence to state of Michigan opioid law. Consequently, the evidence-based
chronic non-malignant pain management protocol provided quality care to all chronic nonmalignant pain management patients in a rural primary care practice.
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Appendix A
Rate of Opioid Related Death

Rate of Opioid related deaths in Michigan. National Institute of Drug Abuse. (2018). Opioidrelated overdose deaths. Retrieved from https://www.drugabuse.gov/drugs-abuse/opioids/opioidsummaries-by-state/michigan-opioid-summary
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Appendix B
CDC Guidelines for Prescribing Opioids for Chronic Pain
Determining When to Initiate or Continue Opioids
for Chronic Pain
1.Nonpharmacologic therapy and non-opioid
pharmacologic therapy are preferred for chronic pain.
Clinicians should consider opioid therapy only if
expected benefits for both pain and function are
anticipated to outweigh risks to the patient. If opioids
are used, they should be combined with
nonpharmacologic therapy and non-opioid
pharmacologic therapy, as appropriate.
2. Before starting opioid therapy for chronic pain,
clinicians should establish treatment goals with all
patients, including realistic goals for pain and function,
and should consider how opioid therapy will be
discontinued if benefits do not outweigh risks.
Clinicians should continue opioid therapy only if there is
clinically meaningful improvement in pain and function
that outweighs risks to patient safety.
3. Before starting and periodically during opioid
therapy, clinicians should discuss with patients known
risks and realistic benefits of opioid therapy and patient
and clinician responsibilities for managing therapy.
Opioid Selection, Dosage, Duration, Follow-up, and
Discontinuation
4. When starting opioid therapy for chronic pain,
clinicians should prescribe immediate-release opioids
instead of extended-release/long-acting (ER/LA)
opioids.
5. When opioids are started, clinicians should prescribe
the lowest effective dosage. Clinicians should use
caution when prescribing opioids at any dosage, should
carefully reassess evidence of individual benefits and
risks when considering increasing dosage to ≥50
morphine milligram equivalents (MME)/day, and should
avoid increasing dosage to ≥90 MME/day or carefully
justify a decision to titrate dosage to ≥90 MME/day.
6. Long-term opioid use often begins with treatment of
acute pain. When opioids are used for acute pain,
clinicians should prescribe the lowest effective dose of
immediate-release opioids and should prescribe no
greater quantity than needed for the expected duration of
pain severe enough to require opioids. Three days or less
will often be sufficient; more than seven days

7. Clinicians should evaluate benefits and harms with
patients within 1 to 4 weeks of starting opioid therapy
for chronic pain or of dose escalation. Clinicians should
evaluate benefits and harms of continued therapy with
patients every 3 months or more frequently. If benefits
do not outweigh harms of continued opioid therapy,
clinicians should optimize other therapies and work with
patients to taper opioids to lower dosages or to taper and
discontinue opioids.
Assessing Risk and Addressing Harms of Opioid Use
8. Before starting and periodically during continuation of
opioid therapy, clinicians should evaluate risk factors for
opioid-related harms. Clinicians should incorporate into
the management plan strategies to mitigate risk,
including considering offering naloxone when factors
that increase risk for opioid overdose, such as history of
overdose, history of substance use disorder, higher
opioid dosages (≥50 MME/day), or concurrent
benzodiazepine use, are present.
9. Clinicians should review the patient’s history of
controlled substance prescriptions using state
prescription drug monitoring program (PDMP) data to
determine whether the patient is receiving opioid
dosages or dangerous combinations that put him or her at
high risk for overdose. Clinicians should review PDMP
data when starting opioid therapy for chronic pain and
periodically during opioid therapy for chronic pain,
ranging from every prescription to every 3 months.
10. When prescribing opioids for chronic pain, clinicians
should use urine drug testing before starting opioid
therapy and consider urine drug testing at least annually
to assess for prescribed medications as well as other
controlled prescription drugs and illicit drugs.
11. Clinicians should avoid prescribing opioid pain
medication and benzodiazepines concurrently whenever
possible.
12. Clinicians should offer or arrange evidence-based
treatment (usually medication assisted treatment with
buprenorphine or methadone in combination with
behavioral therapies) for patients with opioid use
disorder.

CDC (2016). CDC Guideline for Prescribing Opioids for Chronic Pain. Retrieved from
https://www.cdc.gov/drugoverdose/prescribing/guideline.html
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Appendix C
Michigan House Bill No. 4408
Act No. 246
Public Acts of 2017
Approved by the Governor
December 27, 2017
Filed with the Secretary of State December 27, 2017
EFFECTIVE DATE: December 27, 2017
STATE OF MICHIGAN
99TH LEGISLATURE
REGULAR SESSION OF 2017

Introduced by Reps. Bellino and Griffin
ENROLLED HOUSE BILL No. 4408
Sec. 7303c. (1) Except as otherwise provided in this section, beginning June 1, 2018, before a
controlled substance that is an opioid is prescribed to a patient, a licensed prescriber or another
health professional shall provide information on all of the following to the patient or the patient’s
representative:
(a) The danger of opioid addiction.
(b) How to properly dispose of an expired, unused, or unwanted controlled substance.
(c) That the delivery of a controlled substance is a felony under Michigan law.
(d) If the patient is pregnant or is a female of reproductive age, the short- and long-term effects
of exposing a fetus to a controlled substance, including, but not limited to, neonatal abstinence
syndrome. (2) After providing the information described in subsection (1), the licensed
prescriber or other health professional shall obtain the signature of the patient or the patient’s
representative on a form prescribed by the department of health and human services, indicating
that the patient or the patient’s representative has received the information described in
subsection (1). The licensed prescriber or other health professional shall include the signed form
in the patient’s medical or clinical record.
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Appendix D
Burke-Litwin Causal Model

Adapted from “A Causal Model of Organizational Performance and Change,” by W. W. Burke
and G. H. Litwin, 1992, Journal of Management, 18, 528. Copyright 1992 by Southern
Management Association.
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Appendix E
Data Codebook
Data Set Label

Variable
Label

Variable
Description

Attribute
Variable
Descriptor &
Format
Classification
Categories
PARTICIPANT PARTICIPANT Participant
0-99, 9999= Not Numeric
_CODE
Identificatio assessed, 8888=
n Number
Missing Data
PARTICIPANT PARTICIPANT Primary
0= provider 1, 1= Categorical
_PCP
Care
Provider 2
Provider
PARTICIPANT AGE_CLASS
Participants #
Numeric
Age
MEDICAL
DISEASE_
Chronic
0= yes, 1= No,
Categorical
CHRONIC
pain
9999= Not
PAIN
assessed, 8888=
Missing Data
PARTICIPANT PARTICIPANT Patient new 0=new,
Categorical
_NEW OR
or patient is 1=existing
EXISTING
existing
Pre Intervention is BELOW and marked T1
PORTAL
PORT_STAT_
Portal Status
0= Active,
Categorical
T1
Pre1=Inactive
Intervention
MEDICAL
MEDS_T1
Number of
0-99, 9999= Not Numeric
medications
assessed, 8888=
prescribed for Missing Data
pain control on
file
PORTAL
PAIN_SCORE
Documented
0= yes, 1= no
Categorical
T1
pain score in
patients chart
PORTAL
MAPS_T1
PDMP
0=yes, 1=no
Categorical
completed
with visit and
scanned into
chart
PORTAL
UDS_T1
UDS up to
0= yes, 1= no
Categorical
date in chart
PORTAL
EDUCATION_
Signed
0=yes, 1=no
Categorical
T1
education form
on file
PORTAL
MEDICATION_ Medication
0=opioids only,
Categorical

Measure
Level

Scale

Nominal

Scale
Nominal

Nominal

Nominal

Scale

Nominal

Nominal

Nominal
Nominal

Nominal
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CLASS_T1

classes

PORTAL

MEDICATION_
PRESCRIBED_
T1

Medication
prescribed for
pain control
management

Categorical

Nominal

PORTAL

CONTRACT_
Pain contract
0=yes, 1=no
Categorical
T1
Post Intervention is BELOW and marked T2
PORT_STAT_
Portal Status
0= Active, 1=
Categorical
T2
PostInactive
Intervention
MEDS_T2
Number of
0-99, 9999= Not Numeric
medications
assessed, 8888=
prescribed for
Missing Data
pain control on
file
PAIN_SCORE_
Documented
0= yes, 1= no
Categorical
T2
pain score in
patients chart
MAPS_T2
PDMP
0=yes, 1=no
Categorical
completed with
visit and
scanned into
chart
UDS_T2
UDS up to date 0= yes, 1= no
Categorical
in chart
EDUCATION_
Signed
0=yes, 1=no
Categorical
T2
education form
on file
MEDICATION_ Medication
0=opioids only,
Categorical
CLASS_T2
classes
1=non-opioids
only, 2=

Nominal

PORTAL

MEDICAL

PORTAL

PORTAL

PORTAL
PORTAL

PORTAL

1=non-opioids
only, 2=
multimodal
0=oxycodoneacetaminophin,
1=oxycodone,
2=oxycontin, 3=
morphine, 4
=tramadol,
5=NSAIDS,
6=acetaminophe
n, 7=pregabalin/
Neurontin 8=Tricyclic
antidepressants9
=SNRI,
10=Tylenol #3

Nominal

Scale

Nominal

Nominal

Nominal
Nominal

Nominal

51
Running head: CHRONIC NON-MALIGNANT PAIN PROTOCOL

PORTAL

MEDICATION_
PRESCRIBED_
T2

Medication
prescribed for
pain control
management

PORTAL

CONTRACT_T2

Pain contract

multimodal
0=hydrocodone- Categorical
acetaminophen,
1=oxycodone,
2=oxycontin, 3=
morphine, 4
=tramadol,
5=NSAIDS,
6=acetaminophe
n, 7=pregabalin/
Neurontin 8=Tricyclic
antidepressants9
=SNRI,
10=Tylenol #3
0=yes, 1=no

Categorical

Nominal

Nominal
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Appendix F
IRB Approval
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Appendix G
Pre-Intervention Opioid Prescribing in Clinic

Prescriptions for Pain

n =0 (0%)
Non-opioid analgesics

n=403 (100%) Opioid
containing analgesics

Analysis of baseline opioid prescribing in primary care clinic. n = total patients in rural primary
care practice from June 2016 to May 2018.
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Appendix H
Prescription by Analgesic

Analgesics Currently Prescribed
tylenol #3

0

SNRIs

0

tricyclic Antidepressants

0

pregabalin

0

acetaminophen

0

NSAIDS

0

tramadol

122

morphine

12

oxycodone

45

hydrocodone-acetaminophen

224
0

50

100

150

200

250

Total number of prescriptions by analgesic in primary care clinic from June 2016 to May
2018.
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Appendix I
Number of Sample Pre-Intervention Prescribed Opioids

Reliance on Opioids

100%
n=40

Only opioid-containing analgesic used for pain

Analysis of current state of opioid prescribing of sample of primary care clinic between June
2016 and May 2018.
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Appendix J
SWOT Analysis of the Clinic




Strengths
Small family practice with only two providers
promoting a consistent environment
Private owned family practice promoting a
family atmosphere

Motivated leaders, management and staff that
welcome process improvements







Opportunities
Only independent clinic in several

surrounding areas
Could greatly contribute to the reduction in 
the opioid crisis
Enhanced quality of care by implementing
evidence-base pain management guidelines 

Weaknesses
Current EHR does not have a pain
management worksheet checklist and lacks
reporting capabilities
There is currently no pain management
protocol in place
Recommended evidenced-based guidelines
for pain management are not being used
With a small practice, consideration with
additional workload will need addressed

Threats
Pain management related questions on patient
surveys that influence reimbursement
Patients disagreement with new pain
management practices and decrease opioid
prescriptions
Potential for penalties for non-compliance
with Michigan laws on opioid prescribing
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Appendix K

Articles Identified using keywords
in Cochrane, PubMed and
CINAHL are screened
(n=498)
Records Excluded after
Title/Abstract Seen
(n=369)
Related inappropriate:
Population (n=97)
Intervention (n=122)
Comparison (n=126)
Outcome (n=24)
Some articles were
excluded for multiple
reasons

Included

Eligibility

Screening

Identification

PRISMA Flow Diagram of Systematic Search

Full-text articles assessed for
eligibility (n= 105)

Studies included
(n = 9)

Full-text articles
excluded, with reasons
(n=114) related
To inappropriate:
population (7)
Intervention (n=46)
Comparison (n=54)
Outcomes (n=7)
Some articles were
excluded for multiple
reasons

Flow diagram of search selection process. Adapted from “Preferred reporting items for
systematic reviews and meta-analyses: the PRISMA statement, “by D. Moher, A. Liberati, J.
Tetzlaff, D. Altman, and PRISMA Group. Copyright 2008 by PLoS Medicine.

Running head: CHRONIC NON-MALIGNANT PAIN PROTOCOL
58

Appendix L
Table of Evidence
Author (Year)
Purpose
Anderson
(2015)
Effectiveness
of an opioid
dashboard in
the EHR
increasing
adherence to
practice
guidelines

Design (N)
Pre and post
implementatio
n evaluation
(N=1)

Inclusion
Criteria
Multi-site
Primary care
clinics
Patients ≥18
that use any
individual or
combination
of non-liquid
oral or
transdermal
opioid for 90
days or more

Intervention vs.
Results
Comparison
Implementation of an
Efficacy:
opioid dashboard in theo Post intervention 63% patients
EHR vs. no intervention had an opioid treatment
agreement increased from 49%
o Post intervention urine drug
testing increased from 66% to
86%
o Patients with a completed pain
functional assessment increased
from 33% to 46% after 9
months of dashboard use
o Statistically significant decline
in patients receiving opioid
prescriptions decreased 12.5%
(p=0.036)
o COT also declined from 130
(3.4%) to 1270 (3.1%)
p =0.057

Conclusion
Implementation of an
opioid dashboard in
the EHR was
effective in an
increase in the use of
opioid treatment
agreements, urine
drug testing, pain and
functional
assessments
Limited studies are
available and there is
need for further
studies
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Chapparo
(2012)
Efficacy,
tolerability, and
safety of
combination
therapy for
neuropathic
pain

Double-blind
RCT (N=2)

≥18 years old
with
neuropathic
pain

Chen (2016)
Determine
effectiveness of
implementing
opioid
guidelines in
primary care

A Stanford
retrospective
Pre and post
intervention
evaluation
(N=1)

Gatti (2009)
Determine
efficacy,
adverse effects,
quality of life,

open-label,
prospective,
multicenter
comparison
(N=1)

Primary care
clinics who
prescribe
opioids with
patients ≥18
receiving 3 or
more opioid
prescriptions
during the
evaluation
period being
considered
chronic opioid
users
≥18 years old
with moderate
to severe
chronic
neuropathic

Anticonvulsant + opioid Efficacy:
compared to
o 2 studies found good/moderate
anticonvulsant alone
pain relief for anticonvulsant +
opioid (N=210) compared to
anticonvulsant alone (N=213)
(RR 1.30 [1.04, 1.161]; p =0.02)
Adverse Events:
o 2 studies found participants
dropped out due to adverse
events at a higher rate with
anticonvulsant + opioid
(N=216) than anticonvulsant
alone (N=217) (RR 2.76 [1.47,
5.21]; p=0.002)
Implementation of
Efficacy:
Opioid Risk Tool
o Post intervention found a 14%
presented to clinic staff drop in patients receiving any
with a pre and post
opioid prescription (3.9% to
evaluation to identify
3.4%) p =0.02 and a 19% drop
changes in patient and
in chronic opioid patients from
provider behaviors vs.
2.0% to 1.6% (p=0.03)
no tool
o Chronic opioid urine drug
screening increased 87% (9.2%
to 17%) p=0.005

Multimodal therapy is
better for neuropathic
pain than
monotherapy but is
associated with
greater adverse events
when combining
opioid to
anticonvulsant.

CR oxycodone +
pregabalin compared too
CR oxycodone and
pregabalin alone

The combination of
CR oxycodone and
pregabalin was more
effective in alleviating
neuropathic pain,

Efficacy:
Study found mean reduction in
pain score (score on 0-10
numerical rating scale) was
significantly greater with

Dissemination of
opioid guideline tools
is associated with
increase in urine
toxicology screening
and is feasible to
reduce overall opioid
prescription rates and
increase provider
compliance with
opioid guidelines
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and lowest
effective dose
of combination
CR oxycodone
and pregabalin
for neuropathic
pain

pain

o

o

o

o

Khoromi
(2007)
Efficacy of
combination
therapy for

single-center
four-period,
crossover,
randomized
trial

18 years old to
65 years old in
patients with
chronic
lumbar

morphine +
nortriptyline comparedo
to sustained-release
morphine, nortriptyline
and placebo alone

combination therapy (80%) than
with pregabalin (46%; p<0.003)
or oxycodone CR monotherapy
(76%; p<0.001)
Study found patients receiving
CR oxycodone + pregabalin
were given on average 22% less
CR oxycodone and 51% less
pregabalin than the respective
monotherapy groups
The overall decrease in BPI
scores at the end of treatment
compared to baseline was
70.9% for CR oxycodone +
pregabalin (p = 0.0009) vs. both
monotherapies, 60.7% for CR
oxycodone monotherapy, and
42.8% for pregabalin
monotherapy
Adverse Effects:
The study of CR oxycodone +
pregabalin, (45.1%) (N=10)
produced less adverse events
than CR oxycodone alone
(N=11) (42.2%)
34.8% receiving pregabalin
monotherapy reported no
adverse events
Efficacy:
Study found that only the
combination treatment was
significantly better than placebo
(p=0.04). The analysis of the

improved quality of
life and allowed for
greater dose reduction
compared to drug
alone.

Study results suggest
that opioids, tricyclic
antidepressants, and
combination may be
ineffective in the
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chronic lumbar
radicular pain

Kreb (2018)
Determine
efficacy,
functional
response,
quality of life
and adverse
events of
opioid vs. nonopioid therapy
for chronic
back pain or
hip/knee
osteoarthritis

(N=1)

RCT with
masked
outcome
assessment
(N=1)

radicular pain

≥18 years with
moderate to
severe back
pain or
hip/knee
osteoarthritic
pain for 6
months or
more

first period data only for
average back pain showed that
treatment was significant in the
overall model (p=0.005)
Adverse Event:
o Study found morphine
+nortriptyline produced less
adverse events than morphine
alone

Opioid
(morphine IR, morphine
o
SR, transdermal
fentanyl
hydrocodone/acetamino
phen and oxycodone)
To
Non-opioid
o
(acetaminophen and
NSAIDS) with adjuvant
medications
(nortriptyline,
amitriptyline and
o
gabapentin) or
(pregabalin, duloxetine)
and tramadol or topical
analgesics (capsaicin,
lidocaine)
o

Efficacy:
Study found significant
improvement in pain intensity
in the non-opioid group (p=.03)
(Mean BPI 3.5, SD 1.9) vs.
opioid group (Mean BPI 4.0,
SD 2.0) (95% CI)
Study found ≥30%
improvement in functional
response (59% in opioid group,
60.7% in non-opioid group
(95% CI, -14.4 to 11.0) p=.79
Study found that health related
quality of life did not
significantly differ between two
groups
Adverse Events:
The study found that the opioid
group had significantly more
medication related adverse

treatment of lumbar
radicular pain.
These results stand in
contrast to findings in
painful diabetic
neuropathy and postherpetic neuralgia
where TCAs and
opioids have been
repeatedly shown to
be effective
Study results suggest
that treatment with
opioids was not
superior to non-opioid
treatment for
moderate/severe
choric back and
hip/knee pain
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events than non-opioid group
(p=.9) (95% CI, 0.3to 1.5)

Liebschutz
(2017)
Determine if an
intervention
TOPCARE
improves
guideline
adherence
while
decreasing
opioid misuse
risk

Cluster RCT
(N=1)

Primary care
providers who
had at least 4
patients ≥18
older being
treated with
long term
opioid therapy
(3 opioid
prescriptions
at least 21
days apart in a
6-month
period

Romiro (2011)
Determine
benefits and
safety of
combination
therapy for
inflammatory

RCTs and
Quasirandomized
controlled
clinical trials
(N=18)

≥18 years with
inflammatory
arthritis

TOPCARE intervention Efficacy:
vs. no intervention
o Study found significant
differences in all outcomes
except early pill refills
o Intervention patients were more
likely than control to have
guideline concordant care
(65.9% vs. 37.8%) p < .001,
have an opioid agreement
(65.9% vs. 6.0%) p<.001 and to
undergo at least 1 UDT (74.6%
vs. 57.9%) p<.001
o Greater discontinuation of
opioids in intervention vs.
control (21.3% vs. 16.8%)
p=.08
o Intervention group was more
likely than controls to have
either a 10% dose reduction or
opioid discontinuation (47.1%
vs. 35%) p <.001
At least 2 drugs:
Efficacy:
Acetaminophen,
o 2 studies found combination
Opioids, NSAIDS, and therapy reduces pain better
Neuromodulators to
compared to monotherapy;
monotherapy with one o 1 study found high does NSAID
of the drugs
was significantly better than
low dose combination therapy

TOPCARE
intervention
tripled
guideline concordant
opioid monitoring

Evidence is limited to
conclude combination
therapy is better for
inflammatory arthritis
pain than
monotherapy
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arthritis

Romano (2009)
Determine the
efficacy and
adverse effects
of celecoxib
with pregabalin
for chronic low
back pain

Prospective
RCT (N=1)

o 15 studies found no difference
Adverse Events:
o 1 study found monotherapy had
significantly more study
withdrawals compared to
combination therapy; 7 studies
found no difference
o 1 study found combination
therapy had more adverse
events than monotherapy; 9
studies found no difference
≥18 years old
Celecoxib + placebo to Efficacy:
with chronic
pregabalin + placebo o Study found significant
low-back pain to celecoxib +
reduction in pain with patients
(symptoms
pregabalin.
with LANSS score <12 (N=20)
duration: [6
with greatest pain reduction
months, mean:
with patients with LANSS score
13 ± 6
>12 (N=16)
months) due to
o Celecoxib + placebo (all
disc prolapse,
patients, N = 36) (Mean 39.5,
lumbar
SD 12.2) p= 0.06
spondylosis,
o Celecoxib + placebo (LANSS
and/or spinal
<12, N = 20) (Mean 32.5, SD
stenosis;
15.5) p= 0.01
o Celecoxib + placebo (LANSS
>12, N = 16) (Mean 45.7, SD
14.3) p= 0.8
o Pregabalin + placebo (N = 36)
(Mean 43.1, SD. 13.5)
p = 0.12
o Pregabalin + placebo
(LANSS<12, N = 20) (Mean
50.7, SD 13.8) p= 0.76

Combination of
celecoxib and
pregabalin provided
better pain relief for
chronic low back pain
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o Pregabalin + placebo
(LANSS>12, N = 16) (Mean
36.3, SD 12.7) p= 0.03
o Celecoxib + pregabalin (all
patients, N = 36) (Mean 28.6,
SD 15.1) p= 0.0001
o Celecoxib + pregabalin
(LANSS <12, N = 20) (Mean
32.9, SD 13.9) p=0.009
o Celecoxib + pregabalin
(LANSS >12, N = 16) (Mean
23.1 SD 14.6) p=0.0001
Adverse Events:
o Study found participants
dropped out due to adverse
events at a higher rate with
celecoxib + pregabalin (N=7)
than celecoxib + placebo (N=4)
and pregabalin + placebo
(N=5)
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Appendix M
The PARiHS Framework

Implementation framework. Reprinted from “Enabling the implementation of evidence based
practice: a conceptual framework,” by A. Kitson, G. Harvey, & B. McCormack, 1998, Quality in
Health Care: QHC, 7, p. 149-158. Copyright 1998 by Quality in Health Care.
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Appendix N
Kotter’s Eight Step Change Model

Reprinted from Kotter, J. P. (1996). Why transformation efforts fail. The Journal of Product
Innovation Management, 2, 170.
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Appendix O
Project Timeline

November
26

December
1-15

January 3

January 3 March 3

March 3

• Complete proposal and acceptance of project by faculty at Grand
Valley State University and site mentor.

The DNP student will provide will meet with providers and staff
providing education about project and formation of protocol.
Go live with pilot project, implementation of the proposed quality
improvement

The DNP student will meet with office staff weekly.

Project intervention completion. Data will be analyzed and sent
to the statistician.

Final data analysis.
April 5

Study results distributed to project site.
April 10

Final project defense at Grand Valley State University.
April 16
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Appendix P
Medication Algorithm

Pain Condition

First Line Pain Treatment

Later Line Pain Treatment

Osteoarthritis

NSAIDS (including Cox-2 inhibitors)
Acetaminophen
Hyaluronic acid
Intraarticular injectable corticosteroids

Opioids (weak and strong)

Gout

Colchicine
NSAIDs (including Cox-2 inhibitors)
Oral corticosteroids

Adrenocorticotropic hormone

Fibromyalgia

Pregabalin and gabapentin

Opioids (weak and strong,
except tramadol)

SNRI’s (all)
TCAs (all)

Acetaminophen
NSAIDs

Abbreviations: NSAIDS, non-steroidal anti-inflammatory drugs; SNRIs, serotoninnorepinephrine reuptake inhibitors; SSRIs, selective serotonin reuptake inhibitors; TCAs,
tricyclic antidepressants

Margolis, J. M., Princic, N., Smith, D. M., Abraham, L., Cappelleri, J. C., Shah, S. N., & Park, P.
W. (2017). Development of a novel algorithm to determine adherence to chronic pain
treatment guidelines using administrative claims. Journal of pain research, 10, 327-339.
doi:10.2147/JPR.S118248
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Appendix Q
Opioid Start Talking Form
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Appendix R
Budget for DNP Project
Initial Cost: Evidence-based Pain Management
Transitioning focus from opioids to multimodal
analgesia for pain management
Revenue
Project Manager Time (in-kind donation)
Team Member Time:
Statistician (in-kind donation)
Potential cost mitigation 3.8-day Hospitalization (1-year
period) (Prevention of 1 hospitalization and 1 ED visit
related to opioid overdose per year)

29,497.00

PROJECTED TOTAL INCOME

32,147.00

Expenses
Project Manager Time (in-kind donation)
Statistician (in-kind donation)
Team Member Time:
MA’s (extra time spent in staff meeting to be educated on
pilot project)
Registered Nurses (extra time spent in staff meeting to
be educated on pilot project)
Educate NP (time spent reading education on pilot
project)
Educate Physicians (time spent reading education on pilot
project)
Consultation with other primary care clinic to review
practices(one-time cost occurrence)

Educational flyers, a professionally printed
paper, whitepaper, and binder
TOTAL EXPENSES
PROJECTED RETURN ON INVESTMENT

2,550.00
100.00

2,550.00
100.00

6.35
7.50
196.00
360.00
120.00
100.00
3439.85
28,707.15
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Appendix S
Post-Implementation Prescribing

Medication Class Prescribed

n = 36
opioids only
non-opioids only
n = 11

multimodal

n = 94

Total post-implementation prescribing in primary care practice. (n = number of patients for each
prescribing category) in pilot study from January 3, 2019 to March 3, 2019.
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Appendix T
Post-Implementation Increase in Multi-modal Prescribing
120
n = 110
100

n = 94

80

60

T1
T2
n = 36

40

n = 19

20

n = 12 n = 11

0
opioids only

non-opioid only

Multimodal

Change in prescribing practice pre to post-implementation (n = number of patients for each
prescribing practice).
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Appendix U
Change in Prescribing by Medication Class
70
60

n = 65
n =63

n = 58

50

n = 54

n = 46
n = 38

40
30

n = 20
20
10

n = 14

n = 13

n=3

n = 12 n = 12
n=5

n=6

n = 14 n = 13
n=7
n=6

T1
T2

0

Change in prescribing pre and post-implementation (n = number of patients prescribed a specific
analgesic)
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Appendix V
Post-Implementation Percentage Change in Prescribing by Class
60
50
40
30
20
10
0

Percentage change in prescribing practice by analgesic pre and post-implementation.

T1
T2
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Appendix W
Post-Implementation Protocol Adherence

n = 100

100

n = 86

90

n = 78

n = 77

80
70
60
50

40

n = 36

T1

n = 36

T2

n = 20

30
20

n=5

10
0
UDS up to date
(74.47%)

Signed Opioid Start
Signed Pain
Talking Form
Contract (85.82%)
(74.47%)

PDMP completed
with visit (96.45%)

Change in protocol adherence pre and post-implementation for opioid prescribing laws
(n=number of patients adherent to protocol in T1 compared to T2)

